Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 10,718 shares at $2.65 ($28K) on 2025-10-07, disclosed to the SEC on 2025-10-07.
Scheduled sale ($28k) by CEO, Medicare Advantage under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.59 | 8,706 | $23K | 80.9% |
| 2 | $2.65 | 2,012 | $5K | 19.1% |
| Total | $2.60 avg | 10,718 | $28K | 100% |
| Filing → |
| CLOV | SELL | 2026-09-18 | $9K | — | Filing → |
| CLOV | SELL | 2026-09-15 | $44K | — | Filing → |
| CLOV | SELL | 2026-07-17 | $22K | — | Filing → |